All Industries

Top pharmaceuticals Companies

26 pharmaceuticals companies, sorted by total funding raised.

26

Companies

$4.0B

Combined Funding

Series A

Top Stage

Indexed tracks 26 pharmaceuticals companies that have collectively raised $4.0B in documented funding. The most-funded pharmaceuticals companies tracked include BridgeBio and Bicycle Therapeutics. Series A is the most common funding stage among pharmaceuticals companies in this dataset.

BridgeBioIPO

BridgeBio makes targeted treatments for genetic diseases.

San Francisco Bay Area, United States201–500Biotech, Life Sciences
Growth Equity·$1.7B·Jan 2024
BT
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, Oncology
Private Equity·$555.0M·Jan 2024
Crinetics Pharmaceuticals, Inc.

R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.

San Diego, United States11–50Biotech, Healthcare
Venture Round·$453.5M·Jan 2026
Rhythm PharmaceuticalsIPO

Biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases

Boston, United States201–500Healthcare, pharmaceuticals
Extension Round·$398.0M·Jul 2025
Genor BiopharmaIPO

Innovation-driven biopharmaceutical company developing and commercializing oncology and autoimmun...

Shanghai, China201–500Biotech, pharmaceuticals
Series B·$160.0M·Jun 2020
CorMedixIPO

Biopharmaceutical company developing and commercializing therapeutic products for prevention and ...

Berkeley Heights, United StatesBiotech, Healthcare
Convertible·$150.0M·Aug 2025
C
CrucellAcquired

Novel vaccine platform

Leiden, Netherlands201–500Biotechnology, pharmaceuticals
Venture Round·$97.0M·Jan 2001
Larimar TherapeuticsIPO

Clinical-stage biotech developing treatments for complex rare diseases, with lead compound target...

Bala Cynwyd, United States51–200Biotech, Healthcare
Venture Round·$80.0M·May 2020
Confo Therapeutics

Biotech company developing novel GPCR-targeting therapeutics using conformation-specific nanobodies.

Ghent, BelgiumBiotechnology, pharmaceuticals
Series A·$67.1M·May 2019
EyePointIPO

Clinical-stage biotech developing innovative sustained-release therapeutics for serious retinal d...

Watertown, United States51–200Biotechnology, Manufacturing
Corporate Round·$60.5M·Mar 2018
Dice TherapeuticsAcquired

Oral small molecules for protein-protein interactions (acquired by Eli Lilly)

South San Francisco, United States51–200Biotech, pharmaceuticals
Series C·$60.0M·Aug 2021
Egle Therapeutics

Clinical-stage pharmaceutical development company.

Suresnes, FranceBiotech, pharmaceuticals
Grant·$52.4M·Mar 2025
ActelionAcquired

Small molecule therapies for cardiovascular diseases

Allschwil, Switzerland1001–5000Biotechnology, pharmaceuticals
Series B·$46.0M
Sorriso Pharmaceuticals

Sorriso Pharmaceuticals is a biotechnology company advancing a pipeline of disease-modifying anti...

Sandy, United States1–10Biotech, Drug Discovery
Series A·$31.0M·Dec 2021
NexchemAcquired

Leading Chinese producer of active pharmaceutical ingredients (API) for global markets

Jinhua, China11–50pharmaceuticals
Series A·$27.0M·Apr 2011
Rigel PharmaceuticalsIPO

Clinical-stage drug development company that discovers and develops novel, small-molecule drugs f...

South San Francisco, United States51–200Healthcare, pharmaceuticals
Venture Round·$21.4M·Jan 1999
AT
Arteaus TherapeuticsAcquired

Migraine prevention therapy

Cambridge, United States1–10Biotech, neurology
Series A·$18.0M·Oct 2011
SavaraIPO

A clinical stage biopharmaceutical company focused on rare respiratory diseases.

Austin, United States51–200Biotech, Healthcare
Series B·$17.4M·Mar 2013
Diligent Pharma

Centralized vendor management platform for clinical trial sponsors to streamline discovery, quali...

Princeton, United States11–50pharmaceuticals
Series A·$8.3M·May 2023
EpiCept

Specialty pharmaceutical company

Tarrytown, United States11–50Healthcare, pharmaceuticals
Series A·$2.0M·Feb 2012
ArQuleAcquired

Novel cancer drugs (acquired by Merck)

Burlington, United States1–10Oncology, pharmaceuticals
Funding undisclosed
Biograil

Breakthrough technology for the oral delivery of biologics

Roskilde, Denmark11–50Biotechnology, drug_delivery
Venture Round·Jul 2025
BM
Blue Mountain

Asset management for life sciences

Port Matilda, United StatesCompliance, life_sciences
Private Equity·Jan 2026
Dura PharmaceuticalsAcquired

Synthetic peptides for treatment of allergies and asthma

San Diego, United States1001–5000peptides, pharmaceuticals
Funding undisclosed
Haleon plcIPO

British multinational consumer healthcare company focused on everyday health products including S...

Weybridge, United Kingdom10001+consumer healthcare, E-Commerce
Funding undisclosed

Frequently Asked Questions

How many pharmaceuticals companies are tracked on Indexed?

Indexed tracks 26 pharmaceuticals companies, sorted by total funding raised.

How much funding have pharmaceuticals companies raised in total?

The pharmaceuticals companies tracked by Indexed have collectively raised $4.0B in documented funding.

What are the top-funded pharmaceuticals companies?

The most-funded pharmaceuticals companies tracked include BridgeBio, Bicycle Therapeutics, Crinetics Pharmaceuticals, Inc..

Explore More

Other Industries